Retractable Technologies (NYSE:RVP) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Retractable Technologies (NYSE:RVP) in a research report sent to investors on Wednesday morning. The brokerage issued a hold rating on the stock.

Retractable Technologies Stock Performance

Shares of Retractable Technologies stock opened at $0.62 on Wednesday. Retractable Technologies has a 52 week low of $0.56 and a 52 week high of $1.34. The firm has a fifty day moving average of $0.71 and a two-hundred day moving average of $0.93. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.92 and a current ratio of 8.57. The stock has a market capitalization of $18.56 million, a price-to-earnings ratio of -1.15 and a beta of 2.06.

Insider Buying and Selling at Retractable Technologies

In other news, CEO Thomas J. Shaw bought 71,422 shares of the firm’s stock in a transaction dated Friday, September 20th. The shares were bought at an average price of $0.82 per share, with a total value of $58,566.04. Following the completion of the transaction, the chief executive officer now owns 14,743,907 shares of the company’s stock, valued at $12,090,003.74. This trade represents a 0.49 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders have acquired 179,515 shares of company stock worth $143,037 over the last 90 days. Company insiders own 55.00% of the company’s stock.

Institutional Trading of Retractable Technologies

An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC purchased a new position in shares of Retractable Technologies, Inc. (NYSE:RVP) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned approximately 0.12% of Retractable Technologies at the end of the most recent quarter. 7.58% of the stock is owned by institutional investors and hedge funds.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.